A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Press

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

07 Apr 2022

Sustainable Views, Financial Times: Healthcare stewards see success on access to vaccines

The Access to Medicine Foundation's Director of Strategy, Damiano de Felice, spoke with Financial Times journalist Angus Peters for an article examini...

01 Apr 2022

What’s the use of anti-HIV injections when those who need it most can’t use it?

In an article for the Mail & Guardian, Yogan Pillay, Francois Venter and Fatima Hassan examine access to the HIV pre-exposure prohpylaxis (PrEP)...

22 Feb 2022

Swissinfo: Can Novartis’s sustainability-linked bond make good on its promises?

In a long-read for Swissinfo, Jessica Davis Plüss explores different viewpoints on the sustainability-linked bond launched by the Swiss pharmaceutical...

11 Jan 2022

Podcast | What COVID-19 has laid bare about global health priorities

The Access to Medicine Foundation's Margo Warren was interviewed on the EMG GOLD Podcast, sharing insights into what the key issues are right now – an...

13 May 2021

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Author Kristen Hallam for S&P Global covers key themes shaping the current and future health sector.

29 Apr 2021

Operation Vaccines: Access All Areas

Writing in the April edition of EMG's GOLD magazine, author Michaila Byrne investigates how pharma companies are taking action to improve COVID-19 vac...

31 Mar 2021

R&D gap stymies access to children’s medicines – report

Laura Owings for SciDevNet covers the Access to Medicine Foundation's most recent research about the access gap for paediatric medicines. 

30 Mar 2021

EMG Gold Podcast - Talking to Claudia Martínez

On this episode of the EMG Gold Podcast, Claudia Martínez, Research Programme Manager for the Access to Medicine Index, speaks about the work of the A...

29 Mar 2021

Stewardship / Resistance Scan for Mar 29, 2021

Chris Dall for CIDRAP writes about the Access to Medicine Foundation's analysis on the access gap for paediatric medicines.

29 Mar 2021

Only 7% of pharma research projects target children below 12: report

The Hindu Business line writes about the latest analysis from the Access to Medicine Foundation, which investigates the access gap for paediatric medi...

25 Mar 2021

Farmaceuten ontwikkelen bijna geen medicijnen voor kinderen

Karel Berkhout for Dutch news outlet NRC covers the latest paediatric finding from the 2021 Access to Medicine Index. 

21 Mar 2021

Jayasree K. Iyer on BBC: How has COVID-19 exposed the global shortage of medical oxygen?

In this episode of the BBC World Service, Jayasree K. Iyer joins Julian Worricker to discuss the worldwide shortage of medical oxygen. 

23 Feb 2021

Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response

Ed Silverman of Stat News covers investors' call to action for equitable access to COVID-19 treatments and vaccines. 

23 Feb 2021

Asset managers call for ‘fair and equitable’ global efforts to end pandemic

Natalie Kenway for ESG Clarity writes about nearly 150 global investors' call to action for equitable access to COVID-19 treatments and vaccines....

23 Feb 2021

Global petition to help third world countries get medical resources to fight COVID

Glenda Korporaal for the Australian Business Network writes about investors' call to action for equitable access to COVID-19 treatments and vaccines.&...

23 Feb 2021

Daily ESG Briefing: Investors unite to call for fair access to Covid vaccines

Dominic Webb for Responsible Investor includes investors' call for equitable COVID-19 treatments and vaccines in a daily roundup of global ESG news.&n...

Get in touch

Back to top |